Nitric oxide and host defense against Pneumocystis carinii infection in a mouse model

被引:38
|
作者
Shellito, JE
Kolls, JK
Olariu, R
Beck, JM
机构
[1] VET ADM MED CTR, PULM & CRIT CARE MED SECT, ANN ARBOR, MI USA
[2] UNIV MICHIGAN, MED CTR, DEPT INTERNAL MED, ANN ARBOR, MI USA
来源
JOURNAL OF INFECTIOUS DISEASES | 1996年 / 173卷 / 02期
关键词
D O I
10.1093/infdis/173.2.432
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
To investigate whether successful host defense against Pneumocystis carinii is dependent on induction of inducible nitric oxide synthase (iNOS) in alveolar macrophages, immunocompetent mice, mice depleted of CD4 lymphocytes with anti-CD4 antibody, and mice with severe combined immunodeficiency (scid) were inoculated intratracheally with P. carinii. Three weeks later, immunocompetent mice had cleared the organisms completely, while CD4 cell-depleted and scid mice were severely infected (scores, 3.6 +/- 0.2 and 2.8 +/- 0.2, respectively), Inflammation scores were significantly higher in CD4 cell-depleted mice (3.4 +/- 0.2) than in scid mice (0.6 +/- 0.2). Minimal iNOS mRNA was detectable in lung tissue from immunocompetent mice; iNOS mRNA was comparable in scid mice and mice inoculated with PBS but was 6-fold higher in CD4 cell-depleted mice, Immunohistochemistry localized iNOS protein to alveolar macrophages in CD4 cell-depleted mice. Thus, iNOS is an unlikely participant in host defense against P. carinii, because enzyme expression does not correlate with either clearance or severity of infection.
引用
收藏
页码:432 / 439
页数:8
相关论文
共 50 条
  • [31] ACTIVITY OF TOPOISOMERASE INHIBITORS AGAINST PNEUMOCYSTIS-CARINII IN-VITRO AND IN AN INOCULATED MOUSE MODEL
    FISHMAN, JA
    QUEENER, SF
    ROTH, RS
    BARTLETT, MS
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (07) : 1543 - 1546
  • [32] Role of cytokines and nitric oxide synthase in host defense against fungal infections
    Granger, DL
    HOST-FUNGUS INTERPLAY, 1997, : 159 - 166
  • [33] Modified 8-aminoquinolines cure mouse Pneumocystis carinii infection
    Shaw, MM
    McChesney, JD
    Nanayakkara, D
    Dias, LRS
    Lee, CH
    Durant, PJ
    Ball, MD
    Smith, JW
    Bartlett, MS
    JOURNAL OF EUKARYOTIC MICROBIOLOGY, 1997, 44 (06) : 40S - 40S
  • [34] A SURVEY OF PNEUMOCYSTIS-CARINII INFECTION IN RESEARCH MOUSE COLONIES IN JAPAN
    SERIKAWA, T
    KITADA, K
    MURAGUCHI, T
    YAMADA, J
    LABORATORY ANIMAL SCIENCE, 1991, 41 (05): : 411 - 414
  • [35] Discontinuation of chemoprophylaxis against Pneumocystis carinii pneumonia in patients with HIV infection
    Yangco, BG
    Von Bargen, JC
    Moorman, AC
    Holmberg, SD
    ANNALS OF INTERNAL MEDICINE, 2000, 132 (03) : 201 - 205
  • [36] ISG15 in Host Defense Against Candida albicans Infection in a Mouse Model of Fungal Keratitis
    Dong, Chen
    Gao, Nan
    Ross, Bing X.
    Yu, Fu-Shin X.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (07) : 2948 - 2958
  • [37] A rat model for combined Trypanosoma cruzi and Pneumocystis carinii infection
    Oz, HS
    Hughes, WT
    Varilek, GW
    MICROBIAL PATHOGENESIS, 2000, 29 (06) : 363 - 365
  • [38] PROTEIN-CALORIE MALNUTRITION - HOST DETERMINANT FOR PNEUMOCYSTIS-CARINII INFECTION
    HUGHES, WT
    PRICE, RA
    SISKO, F
    HAVRON, WS
    KAFATOS, AG
    SCHONLAND, M
    SMYTHE, PM
    AMERICAN JOURNAL OF DISEASES OF CHILDREN, 1974, 128 (01): : 44 - 52
  • [39] Role of gamma interferon in the host immune and inflammatory responses to Pneumocystis carinii infection
    Garvy, BA
    Ezekowitz, RAB
    Harmsen, AG
    INFECTION AND IMMUNITY, 1997, 65 (02) : 373 - 379
  • [40] Immunization With A Novel Pneumocystis Antigen To Augment Host Defense Against Murine Pneumocystis Pneumonia
    Ruan, S.
    Cai, Y.
    Welsh, D.
    Ramsay, A. J.
    Shellito, J. E.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191